arrow
C

Carmen Salvador Coloma

Hospital Universitari i Politecnic La Fe
H指数:12
被引数:445

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor-educated macrophages promote cytokine-driven lung colonization in triple-negative breast cancer

肿瘤教育性巨噬细胞促进细胞因子驱动的三阴性乳腺癌肺转移定殖

2026-06-190
OA
PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group (SEPT, 10.1007/s12094-025-04048-z, 2025)

卵巢癌患者中PARP抑制剂相关血栓的研究:西班牙医学肿瘤学会(SEOM)血栓与癌症组(SEPT)的研究(10.1007/s12094-025-04048-z, 2025)

2025-11-010
OAAI
PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group

卵巢癌患者中与PARP抑制剂相关的血栓形成:西班牙肿瘤学会(SEOM)血栓形成与肿瘤研究小组的研究

2025-09-070
OAAI
Thrombosis in breast cancer patients on cyclin-dependent kinase inhibitors: Survival impact and predictive factors - A study by the cancer and thrombosis group of the spanish society of medical oncology (SEOM)
2024-12-013
OAAI
Poly (ADP-Ribose) polymerase inhibitors (PARPI): Associated thrombosis in patients with ovarian cancer

Poly (ADP-Ribose) polymerase inhibitors (PARPI):卵巢癌患者中的相关血栓形成

2024-09-010
PRE
Sustained long-term responders to niraparib maintenance in recurrent platinum-sensitive high-grade ovarian cancer (PSROC): A subanalysis of the GEICO-88R study

对于复发性铂敏感高级别卵巢癌(PSROC)中接受尼拉帕利维持治疗的长期持续应答者:GEICO-88R研究的一项亚组分析

2024-09-010
PRE
Tolerability and effectiveness of niraparib in long-term responders with platinum-sensitive recurrent ovarian cancer (GEICO-88R study)
2023-10-010
PRE
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study
2022-11-088
OAAI
High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1

具有ROS1重排的晚期肺癌患者血栓形成的高风险

2020-12-0117
PREAI
Prophylaxis and treatment of venous thromboembolism: data on a survey amongst members of the Spanish Medical Oncology Society
2018-04-010
PREAI
Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer
2018-03-2133
OAAI